Early Change in Metabolic Tumor Heterogeneity during Chemoradiotherapy and Its Prognostic Value for Patients with Locally Advanced Non-Small Cell Lung Cancer.
INTRODUCTION:To observe the early change of metabolic tumor heterogeneity during chemoradiotherapy and to determine its prognostic value for patients with locally advanced non-small cell lung cancer (NSCLC). METHODS:From January 2007 to March 2010, 58 patients with NSCLC were included who were recei...
Main Authors: | Xinzhe Dong, Xiaorong Sun, Lu Sun, Peter G Maxim, Lei Xing, Yong Huang, Wenwu Li, Honglin Wan, Xianguang Zhao, Ligang Xing, Jinming Yu |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2016-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC4913903?pdf=render |
Similar Items
-
Prognostic Value of 18F-FDG PET/CT in Surgical Non-Small Cell Lung Cancer: A Meta-Analysis.
by: Jing Liu, et al.
Published: (2016-01-01) -
Prognostic Usefulness Of Advanced Lung Cancer Inflammation Index In Locally-Advanced Pancreatic Carcinoma Patients Treated With Radical Chemoradiotherapy
by: Topkan E, et al.
Published: (2019-10-01) -
Poor prognostic and staging value of tumor deposit in locally advanced rectal cancer with neoadjuvant chemoradiotherapy
by: Yaqi Wang, et al.
Published: (2019-04-01) -
Prognostic significance of lung radiation dose in patients with esophageal cancer treated with neoadjuvant chemoradiotherapy
by: Jhen-Bin Lin, et al.
Published: (2019-05-01) -
Worse treatment response to neoadjuvant chemoradiotherapy in young patients with locally advanced rectal cancer
by: Yiyi Zhang, et al.
Published: (2020-09-01)